sevelamer


Also found in: Dictionary, Wikipedia.
Related to sevelamer: lanthanum, Cinacalcet

sevelamer

 [sĕ-vel´ah-mer]
a phosphate binder used as the hydrochloride salt to reduce serum phosphorus concentrations in hyperphosphatemia associated with end-stage renal disease; administered orally.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

sevelamer

A phosphate chelator used to reduce phosphorus in patients with end-stage renal disease and in chronic renal failure patients not requiring dialysis. It also reduces uric acid levels, and may be of use in patients with hyperuricaemia, uric acid nephrolithiasis and gout.

Adverse effects
Blood pressure lability (hypo- or hypertension), nausea, vomiting, dyspepsia, diarrhoea, constipation.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

sevelamer

Renagel® Nephrology A chelator used to ↓ phosphorus in Pts with ESRD and in chronic renal failure Pts not requiring dialysis. See Chelation, End-stage renal disease.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
Mentioned in ?
References in periodicals archive ?
Second-quarter Renvela[R] /Renagel[R] (sevelamer) sales decreased 57.3% to [euro]100 million, due to generic competition in the U.S.
Sanofi (NYSE:SNY)
The dose of sevelamer and cinacalcet was modified according to the levels of serum calcium, phosphate, and parathyroid hormone.
Successful treatment of extensive uremic calciphylaxis with intravenous sodium thiosulfate and its potential in treating various diseases of pathologic calcifcation
(BSE: 500124) (NYSE: RDY) has launched Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets, a therapeutic equivalent generic version of Renvela (sevelamer carbonate) for Oral Suspension, in the US market following approved by the US Food and Drug Administration (USFDA), the company said.
Dr. Reddy's Laboratories Launches Sevelamer Carbonate for Oral Suspension in the US Market
Specifically, the electrolyte imbalances were addressed, continuing with the use of noncalcium-containing phosphate binders, such as sevelamer; as well stopping treatment with acenocoumarol that it may contribute to disease's progression.
Sodium thiosulfate and pamidronate for treatment of calciphylaxis: case report/ Tiosulfato de sodio y pamidronato para el tratamiento de calcifilaxis: reporte de caso
A phosphate binder, sevelamer helps to prevent low levels of calcium in the body (hypocalcemia) caused by elevated phosphorus.
Amneal Closes Out Year With Flurry of New Generic Products
Product Monograph PrRENVELA[R] sevelamer carbonate tablets.
ERRATUM
There was evidence that non-CBB like sevelamer was cost-effective in two European countries; the value of this information is limited in the local setting due to differences in health systems and cost structures [17-19].
Cost-Effectiveness Analysis for the Treatment of Hyperphosphatemia in Predialysis Patients: Calcium-Based versus Noncalcium-Based Phosphate Binders
Her home medications included amiodarone, aromasin, aspirin, carvedilol, diltiazem, pantoprazole, sevelamer hydrochloride, cinacalcet, and albuterol.
Colonic Mucosal Ulceration and Gastrointestinal Bleeding Associated with Sevelamer Crystal Deposition in a Patient with End Stage Renal Disease
Indian multinational pharmaceutical and biotech company Cipla (NSE: CIPLA) confirmed on Friday that its subsidiary InvaGen Pharmaceuticals Inc has received final approval from the US Food and Drug Administration (FDA) for Sevelamer Carbonate tablets, 800 mg.
Cipla gets FDA nod for Sevelamer Carbonate tablets
Sevelamer (Renvela and Renagel, Sanofi SA, Paris, France) is the newest member of the resin family.
Challenges in Diagnosing Medication Resins in Surgical Pathology Specimens: A Crystal-Clear Review Guide
Sevelamer has pleiotropic effects on lipid profiles, fibroblast growth factor 23, inflammation, uremic toxins, oxidative stress, and fetuin A and improves endothelial dysfunction.
The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients
Two recent meta-analyses found a reduced risk of all-cause mortality with the non-calcium-based binders sevelamer or lanthanum as compared to calcium-based binders.
Bone disease in patients with kidney disease: a tricky interplay

Medical browser ?
Full browser ?